knowledge -WSS

knowledge

author：entertainment 2025-09-27 12:34:59 - browse：963

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Vivek Ramaswamy made waves in the debate, much as in biotech

focus

Wikipedia

WSS

A controversial new treatment promises to make little people taller

National associations that represent hospice owe an apology

Trans patients at the end of life deserve respect and dignity

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Roche's accidental data boosts hopes for anti

How to ethically and practically extend health care to all

leisure time

knowledge

knowledge

Medical records are filled with copy

Flint parents haunted by uncertainty, fears of lead poisoning

What does generative AI mean for health care? We asked experts

Listen: Vivek Ramaswamy's star turn & leaky drug data

Alkermes shareholders re

Wegovy improves function in certain heart failure patients

Medicare proposal to cover medical devices draws a mixed reaction

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

In age of alternative facts, a scholarly course on calling out crap

FDA advisory panel to debate high blood pressure devices

entertainment

Heart disease in astronauts blamed on cosmic radiation

FDA scientists endorse Pfizer/BioNTech Covid

Physicians aren't 'burning out.' They're suffering from moral injury

Health officials lay out plans to cope with respiratory virus season

When waiting feels immoral: Empathy in the emergency department

Republicans love RFK Jr. What's that tell us about health in 2024?

focus

Wikipedia

hotspot

explore